The value of assets managed with the ESG analysis methodology, which constitute the Group’s Sustainable and Responsible Investment (SRI) products, increased in 2015 to € 28.6 billion. This methodology, developed internally, combines traditional financial and non-financial aspects and considers companies with www.generali-invest.comthe most pronounced ESG performance improvement trends (best effort), making it possible to select the best companies according to the corporate social responsibility and sustainable development policies. The methodology comprises 4 phases (positive screening) and is applied to corporate shares and bonds:
This approach led to the creation of an internal database called S.A.R.A. (Sustainability Analysis of Responsible Asset), thanks to which we have set up a number of dedicated funds. Since 2013, our SRI funds have been awarded the Novethic SRI Label, an international certification for the systematic application of ESG criteria in the investment process.
SRI Ageing Population Fund
In 2015 Generali Investments Europe launched the SRI Ageing Population Fund, a fund that considers the aging population trend and the higher longevity, combining financial returns with the ability to create value for the community.
The selection of securities is based on health care companies (treatment of age-related diseases, cancer, sight, hearing and dental problems etc.), finance companies that offer health and pension policies, and financial products, and companies active in the field of personal services, well-being and recreational activities. Furthermore, all of the companies are chosen and subsequently monitored using the rigorous ESG analysis method developed internally by Generali Investments Europe on the basis of 34 non-financial criteria, which makes it possible to identify solid companies with business models that are sustainable over time.